Straight Path Wealth Management Has $318,000 Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Straight Path Wealth Management decreased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 34.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 35,504 shares of the pharmacy operator’s stock after selling 18,996 shares during the quarter. Straight Path Wealth Management’s holdings in Walgreens Boots Alliance were worth $318,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in WBA. New Covenant Trust Company N.A. acquired a new position in Walgreens Boots Alliance in the 1st quarter valued at $35,000. Iron Horse Wealth Management LLC boosted its position in shares of Walgreens Boots Alliance by 162.5% in the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 1,300 shares during the period. Blue Trust Inc. grew its stake in shares of Walgreens Boots Alliance by 87.0% in the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 1,081 shares in the last quarter. Continuum Advisory LLC increased its position in Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 1,020 shares during the period. Finally, Strategic Investment Solutions Inc. IL bought a new position in Walgreens Boots Alliance during the second quarter worth about $34,000. Institutional investors own 58.59% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on WBA. Bank of America decreased their target price on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research report on Wednesday, September 4th. JPMorgan Chase & Co. reduced their price target on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Barclays lifted their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, October 16th. Morgan Stanley reduced their target price on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a report on Friday, October 11th. Finally, TD Cowen dropped their price target on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research note on Tuesday, October 22nd. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Walgreens Boots Alliance currently has an average rating of “Hold” and an average target price of $12.88.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ WBA traded down $0.33 during mid-day trading on Friday, hitting $8.48. 22,188,371 shares of the stock traded hands, compared to its average volume of 19,571,722. The company has a market cap of $7.33 billion, a PE ratio of -0.85, a price-to-earnings-growth ratio of 1.15 and a beta of 0.69. Walgreens Boots Alliance, Inc. has a twelve month low of $8.22 and a twelve month high of $27.05. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. The firm has a 50 day simple moving average of $9.19 and a two-hundred day simple moving average of $11.90.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company had revenue of $37.50 billion for the quarter, compared to analysts’ expectations of $35.75 billion. During the same period in the previous year, the business posted $0.67 earnings per share. The business’s quarterly revenue was up 5.9% compared to the same quarter last year. As a group, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be issued a dividend of $0.25 per share. The ex-dividend date is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.79%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.